• Media type: E-Article
  • Title: Central Effects of the Designer Drug Mephedrone in Mice—Basic Studies
  • Contributor: Serefko, Anna; Bielecka-Papierz, Gabriela; Talarek, Sylwia; Szopa, Aleksandra; Skałecki, Piotr; Szewczyk, Bernadeta; Radziwoń-Zaleska, Maria; Poleszak, Ewa
  • imprint: MDPI AG, 2022
  • Published in: Brain Sciences
  • Language: English
  • DOI: 10.3390/brainsci12020189
  • ISSN: 2076-3425
  • Keywords: General Neuroscience
  • Origination:
  • Footnote:
  • Description: <jats:p>Mephedrone belongs to the “party drugs” thanks to its psychostimulant effects, similar to the ones observed after amphetamines. Though mephedrone is used worldwide by humans and in laboratory animals, not all properties of this drug have been discovered yet. Therefore, the main aim of this study was to expand the knowledge about mephedrone’s activity in living organisms. A set of behavioral tests (i.e., measurement of the spontaneous locomotor activity, rotarod, chimney, elevated plus maze with its modification, novel object recognition, and pentylenetetrazol seizure tests) were carried out in male albino Swiss mice. Different dose ranges of mephedrone (0.05–5 mg/kg) were administered. We demonstrated that mephedrone at a dose of 5 mg/kg rapidly increased the spontaneous locomotor activity of the tested mice and its repeated administration led to the development of tolerance to these effects. Mephedrone showed the anxiolytic-like potential and improved spatial memory, but it did not affect recognition memory. Moreover, the drug seemed not to have any anticonvulsant or proconvulsant activity. In conclusion, mephedrone induces many central effects. It easily crosses the blood-brain barrier and peaks in the brain quickly after exposure. Our experiment on inducing a hyperlocomotion effect showed that mephedrone‘s effects are transient and lasted for a relatively short time.</jats:p>
  • Access State: Open Access